Survival in sinonasal and middle ear malignancies: a population-based study using the SEER 1973-2015 database.

Q2 Medicine BMC Ear, Nose and Throat Disorders Pub Date : 2018-08-09 eCollection Date: 2018-01-01 DOI:10.1186/s12901-018-0061-4
Mitchell R Gore
{"title":"Survival in sinonasal and middle ear malignancies: a population-based study using the SEER 1973-2015 database.","authors":"Mitchell R Gore","doi":"10.1186/s12901-018-0061-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The sinuses, nasal cavity, and middle ear represent a rarer location of head and neck malignancy than more common sites such as the larynx and oral cavity. Population-based studies are a useful tool to study the demographic and treatment factors affecting survival in these malignancies.</p><p><strong>Methods: </strong>Population-based database search of the Survival, Epidemiology, and End Results (SEER) database from 1973 to 2015 for malignancies involving the nasal cavity, paranasal sinuses, and middle ear. Data were analyzed for demographics, treatment type, stage, primary site and histopathologic type. Kaplan-Meier analysis was used to assess and compare survival.</p><p><strong>Results: </strong>A total of 13,992 cases of sinonasal or middle ear malignancy were identified and analyzed. The majority of patients were between ages 50 and 80 at the time of diagnosis. Overall 5-, 10-, and 20-year survival was 45.7%, 32.2%, and 16.4%, respectively. Lymph node metastasis was reported in 4.4% of patients, while distant metastasis was present in 1.5% of cases. On univariate analysis surgical vs. nonsurgical treatment, sex, race, age at diagnosis, T stage, N stage, M stage, AJCC overall stage, primary site, tumor grade, and histopathologic subtype significantly affected survival. On multivariate analysis age, race, sex, primary site, overall AJCC stage, surgical vs. nonsurgical treatment, and T, N, and M stage remained significant predictors of overall survival.</p><p><strong>Conclusions: </strong>Malignancies of the nasal cavity, paranasal sinuses, and middle ear account for a minority of overall head and neck cancers. The overall 5-, 10-, and 20-year survival for these malignancies is relatively low. Higher T, N, M, and overall stage and higher tumor grade is associated with lower survival. Patients treated with surgery as part of the treatment regimen had higher overall survival. Demographics and primary site also significantly affect survival. Certain histopathologic subtypes were associated with poorer survival.</p>","PeriodicalId":39843,"journal":{"name":"BMC Ear, Nose and Throat Disorders","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12901-018-0061-4","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Ear, Nose and Throat Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12901-018-0061-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 14

Abstract

Background: The sinuses, nasal cavity, and middle ear represent a rarer location of head and neck malignancy than more common sites such as the larynx and oral cavity. Population-based studies are a useful tool to study the demographic and treatment factors affecting survival in these malignancies.

Methods: Population-based database search of the Survival, Epidemiology, and End Results (SEER) database from 1973 to 2015 for malignancies involving the nasal cavity, paranasal sinuses, and middle ear. Data were analyzed for demographics, treatment type, stage, primary site and histopathologic type. Kaplan-Meier analysis was used to assess and compare survival.

Results: A total of 13,992 cases of sinonasal or middle ear malignancy were identified and analyzed. The majority of patients were between ages 50 and 80 at the time of diagnosis. Overall 5-, 10-, and 20-year survival was 45.7%, 32.2%, and 16.4%, respectively. Lymph node metastasis was reported in 4.4% of patients, while distant metastasis was present in 1.5% of cases. On univariate analysis surgical vs. nonsurgical treatment, sex, race, age at diagnosis, T stage, N stage, M stage, AJCC overall stage, primary site, tumor grade, and histopathologic subtype significantly affected survival. On multivariate analysis age, race, sex, primary site, overall AJCC stage, surgical vs. nonsurgical treatment, and T, N, and M stage remained significant predictors of overall survival.

Conclusions: Malignancies of the nasal cavity, paranasal sinuses, and middle ear account for a minority of overall head and neck cancers. The overall 5-, 10-, and 20-year survival for these malignancies is relatively low. Higher T, N, M, and overall stage and higher tumor grade is associated with lower survival. Patients treated with surgery as part of the treatment regimen had higher overall survival. Demographics and primary site also significantly affect survival. Certain histopathologic subtypes were associated with poorer survival.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
鼻和中耳恶性肿瘤的生存率:使用SEER 1973-2015数据库的基于人群的研究
背景:鼻窦、鼻腔和中耳是头颈部恶性肿瘤较少见的部位,较常见的部位如喉和口腔为少见。以人群为基础的研究是研究影响这些恶性肿瘤生存的人口统计学和治疗因素的有用工具。方法:以人群为基础的数据库检索1973年至2015年涉及鼻腔、鼻窦和中耳的恶性肿瘤的生存、流行病学和最终结果(SEER)数据库。对数据进行人口统计学、治疗类型、分期、原发部位和组织病理类型分析。Kaplan-Meier分析用于评估和比较生存率。结果:共检出13992例鼻中耳恶性肿瘤。大多数患者在诊断时年龄在50至80岁之间。总体5年、10年和20年生存率分别为45.7%、32.2%和16.4%。4.4%的患者有淋巴结转移,1.5%的患者有远处转移。在单因素分析中,手术与非手术治疗、性别、种族、诊断时年龄、T期、N期、M期、AJCC总分期、原发部位、肿瘤分级和组织病理学亚型显著影响生存率。在多变量分析中,年龄、种族、性别、原发部位、AJCC总分期、手术与非手术治疗、T、N和M分期仍然是总生存率的重要预测因素。结论:鼻腔、鼻窦和中耳的恶性肿瘤占头颈部肿瘤的少数。这些恶性肿瘤的总体5年、10年和20年生存率相对较低。较高的T、N、M和总分期以及较高的肿瘤分级与较低的生存率相关。作为治疗方案的一部分,接受手术治疗的患者总体生存率更高。人口统计学和原发部位也显著影响生存率。某些组织病理学亚型与较差的生存率相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Ear, Nose and Throat Disorders
BMC Ear, Nose and Throat Disorders Medicine-Otorhinolaryngology
CiteScore
3.30
自引率
0.00%
发文量
0
期刊介绍: BMC Ear, Nose and Throat Disorders is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of ear, nose and throat disorders, as well as related molecular genetics, pathophysiology, and epidemiology. BMC Ear, Nose and Throat Disorders (ISSN 1472-6815) is indexed/tracked/covered by PubMed, CAS, EMBASE, Scopus and Google Scholar.
期刊最新文献
Cochlear implantation as a treatment for single-sided deafness and asymmetric hearing loss: a randomized controlled evaluation of cost-utility. Antimicrobial susceptibility patterns of bacteria isolated from patients with ear discharge in Jimma Town, Southwest, Ethiopia. Staphylococcus aureus from patients with chronic rhinosinusitis show minimal genetic association between polyp and non-polyp phenotypes. Epithelial-myoepithelial carcinoma: a population-based survival analysis. Odontogenic necrotizing fasciitis: a systematic review of the literature.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1